Ipragliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated for the management of type 2 diabetes mellitus by reducing glucose reabsorption in the kidneys. This category provides essential… Read more
![Chemical structure of (1S,2R,3S,4R,5R)-1-(3-(Benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-5-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1S2R3S4R5R-1-3-Benzobthiophen-2-ylmethyl-4-fluorophenyl-5-hydroxymethylcyclohexane-1234-tetraol.png&w=3840&q=75)
![Chemical structure of (2R,3R,4R,5R)-2-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-5-((R)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2R3R4R5R-2-3-benzobthiophen-2-ylmethyl-4-fluorophenyl-5-R-12-dihydroxyethyltetrahydrofuran-34-diol.png&w=3840&q=75)
![Chemical structure of (2R,3R,4R,5S,6R)-2-(3-(Benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2602662-34-8-2R3R4R5S6R-2-3-Benzobthiophen-2-ylmethyl-4-fluorophenyl-6-hydroxymethyltetrahydro-2H-pyran-345-triol.png&w=3840&q=75)
![Chemical structure of (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1034305-21-9-2R3R4R5S6S-2-acetoxymethyl-6-3-benzobthiophen-2-ylmethyl-4-fluorophenyltetrahydro-2H-pyran-345-triyl-triacetate.png&w=3840&q=75)
![Chemical structure of (2R,3S,4R,5R,6S)-2-(Acetoxymethyl)-6-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-4-hydroxytetrahydro-2H-pyran-3,5-diyl diacetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2R3S4R5R6S-2-Acetoxymethyl-6-3-benzobthiophen-2-ylmethyl-4-fluorophenyl-4-hydroxytetrahydro-2H-pyran-35-diyl-diacetate.png&w=3840&q=75)
![Chemical structure of (2S,3R,4R,5R)-1-(3-(Benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)hexane-1,2,3,4,5,6-hexaol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S3R4R5R-1-3-Benzobthiophen-2-ylmethyl-4-fluorophenylhexane-123456-hexaol.png&w=3840&q=75)
![Chemical structure of (2S,3R,4R,5R)-2-(3-(Benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-5-((R)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S3R4R5R-2-3-Benzobthiophen-2-ylmethyl-4-fluorophenyl-5-R-12-dihydroxyethyltetrahydrofuran-34-diol.png&w=3840&q=75)
![Chemical structure of (2S,3R,4R,5R)-2-(3-(Benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-5-(1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2S3R4R5R-2-3-Benzobthiophen-2-ylmethyl-4-fluorophenyl-5-12-dihydroxyethyltetrahydrofuran-34-diol.png&w=3840&q=75)
![Chemical structure of (3R,4S,5S,6R)-2-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetraol](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1922933-61-6-3R4S5S6R-2-3-benzobthiophen-2-ylmethyl-4-fluorophenyl-6-hydroxymethyltetrahydro-2H-pyran-2345-tetraol.png&w=3840&q=75)

![Chemical structure of 2-(2-Fluorobenzyl)benzo[b]thiophene](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3049389-50-3-2-2-Fluorobenzylbenzobthiophene.png&w=3840&q=75)
![Chemical structure of 2-(5-Bromo-2-fluorobenzyl)benzo[b]thiophene](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1034305-17-3-2-5-Bromo-2-fluorobenzylbenzobthiophene.png&w=3840&q=75)



![Chemical structure of Methyl 1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-alpha-D-glucopyranoside](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1034305-23-1-Methyl-1-C-3-benzobthien-2-ylmethyl-4-fluorophenyl-alpha-D-glucopyranoside.png&w=3840&q=75)
Ipragliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated for the management of type 2 diabetes mellitus by reducing glucose reabsorption in the kidneys. This category provides essential materials for pharmaceutical research and quality control, including high-purity reference standards of the parent drug, its pharmacopeial and non-pharmacopeial impurities, and stable isotope labelled compounds. Laboratories utilize these reference standards to conduct accurate impurity profiling, supporting the identification and quantification of degradation products formed through hydrolysis, oxidation, or photolysis. Furthermore, stable isotope labelled compounds are critical for mass spectrometry validation, providing internal standards to ensure precise results. These compounds support analytical method development and stability studies, enabling compliance with strict regulatory requirements for drug safety, efficacy, and consistency throughout the drug development lifecycle.